Cargando…

A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort

OBJECTIVE: To prospectively investigate associations of presurgical body mass index (BMI) with clinicopathological factors and its prognostic significance in radically D2-resected patients with non-metastasized gastric cancer (GC) and Siewert type II/III adenocarcinoma of esophagogastric junction (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lei, Wei, Zhi-Jian, Li, Tuan-Jie, Jiang, Yu-Ming, Xu, A-Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620246/
https://www.ncbi.nlm.nih.gov/pubmed/28978106
http://dx.doi.org/10.18632/oncotarget.19251
_version_ 1783267546338689024
author Huang, Lei
Wei, Zhi-Jian
Li, Tuan-Jie
Jiang, Yu-Ming
Xu, A-Man
author_facet Huang, Lei
Wei, Zhi-Jian
Li, Tuan-Jie
Jiang, Yu-Ming
Xu, A-Man
author_sort Huang, Lei
collection PubMed
description OBJECTIVE: To prospectively investigate associations of presurgical body mass index (BMI) with clinicopathological factors and its prognostic significance in radically D2-resected patients with non-metastasized gastric cancer (GC) and Siewert type II/III adenocarcinoma of esophagogastric junction (AEG). METHODS: A large prospective cohort consisting of radically-resected GC and AEG patients was analyzed. Follow-up was successful in 671 out of 700 patients, who were categorized into underweight (BMI<18.5), normal-weight (BMI=18.5-22.9), overweight (BMI=23-24.9), and obese (BMI≥25) groups according to Asian standards. BMI-associated factors were explored using multivariable logistic regression with adjustment. Cancer-specific survival analyses were conducted applying both univariable and multivariable Cox regression methods. RESULTS: Pre-operation, higher hemoglobin levels and smaller anemia proportions were observed in larger BMI groups. Higher BMI tended to be associated with higher neutrophil-lymphocyte ratios (NLRs). Patients with higher BMI had smaller tumors and more often stage I tumors, but longer surgical time and postsurgical stay. In multivariable analyses, higher hemoglobin levels, upper tumor location, poorer differentiation, and higher NLR were significantly associated with higher BMI. Overall, survival analyses revealed no significant role of BMI. However, in further stratifications after adjustment, compared to patients with normal BMI, obese patients had better survival in women, but worse in those with AEG; underweight was associated with reduced mortality risk in tumors differentiated well to moderately; overweight patients had increased death hazard when having thrombocytopenia. CONCLUSION: Overall, preoperative BMI had limited prognostic significance in operated GC patients. However, under specific conditions (e.g., female, AEG, good differentiation, and thrombocytopenia), BMI might indicate postoperative survival.
format Online
Article
Text
id pubmed-5620246
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56202462017-10-03 A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort Huang, Lei Wei, Zhi-Jian Li, Tuan-Jie Jiang, Yu-Ming Xu, A-Man Oncotarget Research Paper OBJECTIVE: To prospectively investigate associations of presurgical body mass index (BMI) with clinicopathological factors and its prognostic significance in radically D2-resected patients with non-metastasized gastric cancer (GC) and Siewert type II/III adenocarcinoma of esophagogastric junction (AEG). METHODS: A large prospective cohort consisting of radically-resected GC and AEG patients was analyzed. Follow-up was successful in 671 out of 700 patients, who were categorized into underweight (BMI<18.5), normal-weight (BMI=18.5-22.9), overweight (BMI=23-24.9), and obese (BMI≥25) groups according to Asian standards. BMI-associated factors were explored using multivariable logistic regression with adjustment. Cancer-specific survival analyses were conducted applying both univariable and multivariable Cox regression methods. RESULTS: Pre-operation, higher hemoglobin levels and smaller anemia proportions were observed in larger BMI groups. Higher BMI tended to be associated with higher neutrophil-lymphocyte ratios (NLRs). Patients with higher BMI had smaller tumors and more often stage I tumors, but longer surgical time and postsurgical stay. In multivariable analyses, higher hemoglobin levels, upper tumor location, poorer differentiation, and higher NLR were significantly associated with higher BMI. Overall, survival analyses revealed no significant role of BMI. However, in further stratifications after adjustment, compared to patients with normal BMI, obese patients had better survival in women, but worse in those with AEG; underweight was associated with reduced mortality risk in tumors differentiated well to moderately; overweight patients had increased death hazard when having thrombocytopenia. CONCLUSION: Overall, preoperative BMI had limited prognostic significance in operated GC patients. However, under specific conditions (e.g., female, AEG, good differentiation, and thrombocytopenia), BMI might indicate postoperative survival. Impact Journals LLC 2017-07-12 /pmc/articles/PMC5620246/ /pubmed/28978106 http://dx.doi.org/10.18632/oncotarget.19251 Text en Copyright: © 2017 Huang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Huang, Lei
Wei, Zhi-Jian
Li, Tuan-Jie
Jiang, Yu-Ming
Xu, A-Man
A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort
title A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort
title_full A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort
title_fullStr A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort
title_full_unstemmed A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort
title_short A prospective appraisal of preoperative body mass index in D2-resected patients with non-metastatic gastric carcinoma and Siewert type II/III adenocarcinoma of esophagogastric junction: results from a large-scale cohort
title_sort prospective appraisal of preoperative body mass index in d2-resected patients with non-metastatic gastric carcinoma and siewert type ii/iii adenocarcinoma of esophagogastric junction: results from a large-scale cohort
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620246/
https://www.ncbi.nlm.nih.gov/pubmed/28978106
http://dx.doi.org/10.18632/oncotarget.19251
work_keys_str_mv AT huanglei aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT weizhijian aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT lituanjie aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT jiangyuming aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT xuaman aprospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT huanglei prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT weizhijian prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT lituanjie prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT jiangyuming prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort
AT xuaman prospectiveappraisalofpreoperativebodymassindexind2resectedpatientswithnonmetastaticgastriccarcinomaandsiewerttypeiiiiiadenocarcinomaofesophagogastricjunctionresultsfromalargescalecohort